"Organophosphates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Carbon-containing phosphoric acid derivatives. Included under this heading are compounds that have CARBON atoms bound to one or more OXYGEN atoms of the P(=O)(O)3 structure. Note that several specific classes of endogenous phosphorus-containing compounds such as NUCLEOTIDES; PHOSPHOLIPIDS; and PHOSPHOPROTEINS are listed elsewhere.
| Descriptor ID |
D010755
|
| MeSH Number(s) |
D02.705.400
|
| Concept/Terms |
Phosphoric Acid Esters- Phosphoric Acid Esters
- Acid Esters, Phosphoric
- Esters, Phosphoric Acid
- Phosphates, Organic
- Organic Phosphates
|
Below are MeSH descriptors whose meaning is more general than "Organophosphates".
Below are MeSH descriptors whose meaning is more specific than "Organophosphates".
This graph shows the total number of publications written about "Organophosphates" by people in this website by year, and whether "Organophosphates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organophosphates" by people in Profiles.
-
Cluck DB, Chastain DB, Murray M, Durham SH, Chahine EB, Derrick C, Dumond JB, Hester EK, Jeter SB, Johnson MD, Kilcrease C, Kufel WD, Kwong J, Ladak AF, Patel N, P?rez SE, Poe JB, Bolch C, Thomas I, Asiago-Reddy E, Short WR. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary. Pharmacotherapy. 2024 05; 44(5):354-359.
-
Cluck DB, Chastain DB, Murray M, Durham SH, Chahine EB, Derrick C, Dumond JB, Hester EK, Jeter SB, Johnson MD, Kilcrease C, Kufel WD, Kwong J, Ladak AF, Patel N, P?rez SE, Poe JB, Bolch C, Thomas I, Asiago-Reddy E, Short WR. Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy. Pharmacotherapy. 2024 05; 44(5):360-382.
-
Molina-Torres CA, Barba-Marines A, Valles-Guerra O, Ocampo-Candiani J, Cavazos-Rocha N, Pucci MJ, Castro-Garza J, Vera-Cabrera L. Intracellular activity of tedizolid phosphate and ACH-702 versus Mycobacterium tuberculosis infected macrophages. Ann Clin Microbiol Antimicrob. 2014 Apr 04; 13:13.
-
Kirby SD, Norris JR, Richard Smith J, Bahnson BJ, Cerasoli DM. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents. Chem Biol Interact. 2013 Mar 25; 203(1):181-5.
-
Kirk BA, Cusack CL, Laager E, Rochlis E, Thomas T, Cassano AG. Mononuclear and dinuclear mechanisms for catalysis of phosphodiester cleavage by alkaline earth metal ions in aqueous solution. J Inorg Biochem. 2010 Feb; 104(2):207-10.
-
Samanta U, Kirby SD, Srinivasan P, Cerasoli DM, Bahnson BJ. Crystal structures of human group-VIIA phospholipase A2 inhibited by organophosphorus nerve agents exhibit non-aged complexes. Biochem Pharmacol. 2009 Aug 15; 78(4):420-9.
-
Jain MK, Tao WJ, Rogers J, Arenson C, Eibl H, Yu BZ. Active-site-directed specific competitive inhibitors of phospholipase A2: novel transition-state analogues. Biochemistry. 1991 Oct 22; 30(42):10256-68.